Corn Care Patches

Description

The product is identified by SPL code 34089-3. It is presented as a white to off-white, round, biconvex tablet, featuring the imprint "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, magnesium stearate, and sodium starch glycolate.

Uses and Indications

This drug is indicated for the removal of corns and calluses. It provides relief from pain associated with these conditions by effectively removing the corns and calluses.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed and dried thoroughly before application. After ensuring the area is dry, the patch should be attached directly to the affected site. This procedure may be repeated once or twice daily as needed, for a maximum duration of 14 days, or until the corn or callus is completely removed.

To facilitate the removal of the corn or callus, it is recommended to soak the area in warm water for approximately 5 minutes prior to patch application. Additionally, protective pads may be utilized to cushion the corn or callus during the treatment period.

For patients under 12 years of age, it is advised to consult a healthcare professional before proceeding with treatment.

Contraindications

Use is contraindicated in patients with diabetes due to the potential for adverse effects on glycemic control. Additionally, the product should not be used in individuals with poor blood circulation, as this may exacerbate underlying conditions. Application on irritated skin or any area that is infected or reddened is also contraindicated to prevent further irritation or infection.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame to prevent any risk of ignition.

Caution is advised for individuals with specific health conditions. This product should not be used by patients with diabetes or those who have poor blood circulation. Additionally, it is contraindicated for application on irritated skin or any area that is infected or reddened, as this may exacerbate the condition.

In the event of accidental ingestion, it is imperative to seek emergency medical assistance or contact a Poison Control Center immediately.

Healthcare professionals should advise patients to discontinue use and consult a physician if discomfort persists.

Side Effects

Patients should be aware that the product is for external use only and is flammable; it should be kept away from fire or flame to prevent any hazards.

In clinical trials and postmarketing experiences, participants have reported various adverse reactions. Notably, if discomfort persists, it is advised to discontinue use of the product. This precaution is essential to ensure patient safety and to mitigate any potential adverse effects that may arise from continued application.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Corn Care Patches (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional prior to use. It is important to assess the appropriateness of treatment and dosage for this age group, as specific recommendations may vary based on individual health needs and conditions.

Geriatric Use

There is no specific information regarding the use of Corn Care Patches (salicylic acid patch) in geriatric patients. The prescribing information does not indicate any dosage adjustments, safety concerns, or special precautions that are specifically applicable to elderly patients. Therefore, healthcare providers should exercise clinical judgment when considering the use of this product in patients aged 65 and older, as individual patient factors may necessitate careful monitoring and assessment.

Pregnancy

The safety of this product during pregnancy has not been established. Use is not recommended during pregnancy due to potential risks to the fetus. Healthcare professionals should consider alternative treatments for pregnant patients, as the potential for adverse fetal outcomes cannot be ruled out. Women of childbearing potential should be advised to use effective contraception while on this medication to prevent unintended pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, specific antidotes or treatments may be indicated based on the clinical scenario and the substance involved. Consultation with a poison control center or a medical toxicologist is recommended for guidance on the appropriate management strategies.

Overall, vigilance and prompt intervention are critical in managing cases of suspected overdose to mitigate potential complications and ensure patient safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that in the event of accidental ingestion, it is crucial to seek medical assistance immediately or contact a Poison Control Center. This prompt action is essential to ensure the safety and well-being of the patient.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature, ensuring it is kept away from heat sources. Due to its flammable nature, the product must be handled with care, and it should be kept away from fire or flame to prevent any hazards. Proper storage and handling are crucial to maintaining the integrity and safety of the product.

Additional Clinical Information

The product is administered topically, with the recommended procedure to be repeated once or twice daily as needed for up to 14 days, or until the corn or callus is removed. Clinicians should counsel patients regarding specific considerations, including the presence of diabetes or poor blood circulation, and advise against use on irritated, infected, or reddened skin. Patients should be instructed to flush the eyes with water for 15 minutes if the product comes into contact with them, avoid inhaling vapors, and store the product at room temperature away from heat. In the event of ingestion, immediate medical assistance or contact with a Poison Control Center is advised. Additionally, consultation with a doctor is recommended for children under 12 years of age.

Drug Information (PDF)

This file contains official product information for Corn Care Patches, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)